Kendall Kohlmeyer

Kendall Kohlmeyer is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm’s Healthcare team.

Areas of Practice 

Kendall advises healthcare companies on regulatory and transactional matters. Kendall represents entities including individual providers, IPAs, hospitals, medical groups, ambulatory surgery centers, academic medical centers, pharmacies, digital health companies, hospice and home health agencies, and PACE organizations. Her areas of expertise include: the corporate practice of medicine and fee-splitting laws; facility and practitioner licensing requirements; and issues surrounding physician referrals, including the Stark Law and Anti-Kickback Statute, and similar regulations under the laws of various states.

She enjoys advising clients on compliance issues and serving as a healthcare regulatory specialist for mergers, acquisitions, and joint ventures. Kendall helps sellers and buyers on a variety of transactions to identify, assess, and resolve compliance concerns from the start of the due diligence process through post-closing operations.

During her first year at Sheppard Mullin, Kendall proudly dedicated more than 130 pro bono hours to several immigration matters, including petitioning for a family reunification and successfully obtaining status for an asylum-seeker.

Honors

Private Equity Deal of the Year: Lee Fish’s sale to Sole Source Capital, M&A Advisor, 2023

Articles

Healthcare Law Blog Posts

• "FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies," March 21, 2025

• "Massachusetts Senate Passes Bill to Increase Oversight of Private Equity Healthcare Transactions," July 25, 2024

• "OHCA Proposes Amendments to its Cost and Market Impact Review Program," June 13, 2024

• "California is Capping Health Care Cost Increases – Starting at 3.5% in 2025," May 7, 2024

• "CMS Issues CY2025 Medicare Advantage and Part D Final Rule," April 15, 2024

• "OIG Sparks Public Excitement about Managed Care and Alludes to Incoming Enforcement Guidance," April 1, 2024

• "OHCA Published Near-Final Draft of Regulations Requiring Notice and Review of Material Healthcare Transactions in 2024," December 6, 2023

• "CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule," November 13, 2023

• "OHCA’s Revised Regulations Following Comments from Industry Stakeholders," October 24, 2023

• "Public Workshop for OHCA’s Proposed Regulations Sparks Lively Discussion Among Industry Stakeholders," September 7, 2023

• "Part 3: An Update on the Federal and State E-Roe-sion or P-Roe-tection of Abortion Rights," August 9, 2023

• "HHS OIG Publishes Eagerly-Anticipated Federal Information Blocking Enforcement Final Rule," July 5, 2023
• "OIG 2022 Advisory Opinions: Year in Review," May 8, 2023

• "Key Healthcare Provisions of the Consolidated Appropriations Act, 2023," January 6, 2023